Nectar Lifesciences Limited (NSE:NECLIFE)

India · Delayed Price · Currency is INR

14.62

+0.08 (0.55%)

At close: Jan 23, 2026

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	2014 - 2018
Pharmaceuticals Products	19.26B	Log In	Log In	Log In	Log In	Upgrade
Pharmaceuticals Products Growth	10.26%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	2014 - 2018
India	11.46B	Log In	Log In	Log In	Log In	Upgrade
India Growth	35.61%	Log In	Log In	Log In	Log In	Upgrade
International	7.79B	Log In	Log In	Log In	Log In	Upgrade
International Growth	-13.51%	Log In	Log In	Log In	Log In	Upgrade